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Introduction

Management of chronic kidney disease (CKD) is a critical issue in public health
. T a b l e 1 . P a t i e n t s Ch a r a c t e r i s t i c s a c c o r d i n g t o e GF R S t r a t a a n d L e v e l o f Al b u mi n u r i 
Diabetic kidney disease (DKD) is a presumptive diagnosis of kidney disease caused by diabetes, and in clinical set-tings, the presence of albuminuria is essential for diagnosis, although the gold standard is pathological confirmation by kidney biopsy (4). The extent of albuminuria is divided into two groups: microalbuminuria [albumin to creatinine ratio (ACR) 30~299 mg/g creatinine] and macroalbuminuria (ACR >300 mg/g creatinine
T a b l e 2 . Re l a t i o n s h i p b e t we e n e GF R a n d ACR S t r a t a eGFR >90
eGFR 60~89 eGFR 30~59 p-Value* n = 25 n = 154 n = 109 Normoalbuminuric, n (%)
12 (48) 104 (68) 
Discussion
In this survey, patients were relatively young but the prevalence of CKD stage 3 was high. A previous report from the UK (2) revealed that 30% of diabetic patients had CKD stage 3, which was similar to our result indicating a higher prevalence of CKD in diabetic patients than the general population. Our survey also demonstrated that 64% of diabetic patients with CKD stage 3 were normoalbuminuric, in contrast to the results which showed that normoalbuminuric patients were about 20 to 30% in CKD stage 3 patients (11, 12) . ACEIs and ARBs might have modified both ACR and eGFR, although the absolute number of patients on these drugs in our study were fewer than in the previous studies (11, 12 (11, 12 
